D. Vallance

674 total citations
16 papers, 532 citations indexed

About

D. Vallance is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, D. Vallance has authored 16 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 7 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in D. Vallance's work include Lipoproteins and Cardiovascular Health (8 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers) and Lipid metabolism and disorders (3 papers). D. Vallance is often cited by papers focused on Lipoproteins and Cardiovascular Health (8 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers) and Lipid metabolism and disorders (3 papers). D. Vallance collaborates with scholars based in United Kingdom, Australia and Sweden. D. Vallance's co-authors include A F Winder, Jameela A. Kari, Lesley Rees, Anna Leone, Beatriz Dorado, Michael Mullen, K. Richard Bruckdorfer, Ann E. Donald, John Deanfield and F. Mailly and has published in prestigious journals such as Kidney International, Arteriosclerosis Thrombosis and Vascular Biology and Journal of Clinical Pathology.

In The Last Decade

D. Vallance

16 papers receiving 517 citations

Peers

D. Vallance

CCM

EDM

SURGE

NEPHR

PHYSI

P. Brizzi Italy

H Morii Japan

Martin Kammerl Germany

TERUHISA UMEDA Japan

Jwari Ahn United States

Nobukiyo Koide Japan

DN O'Neal Australia

Giovanni Cerasola Italy

Martin M.-T. Fuh Taiwan

P. Brizzi Italy

D. Vallance

143 ×0.5

CCM

225 ×1.2

EDM

255 ×1.4

SURGE

93 ×1.0

NEPHR

103 ×1.2

PHYSI

Citations per year, relative to D. Vallance D. Vallance (= 1×) peers P. Brizzi

Countries citing papers authored by D. Vallance

Since Specialization

Citations

This map shows the geographic impact of D. Vallance's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Vallance with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Vallance more than expected).

Fields of papers citing papers by D. Vallance

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Vallance. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Vallance. The network helps show where D. Vallance may publish in the future.

Co-authorship network of co-authors of D. Vallance

This figure shows the co-authorship network connecting the top 25 collaborators of D. Vallance. A scholar is included among the top collaborators of D. Vallance based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Vallance. D. Vallance is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Chetty, Rajkumar, et al.. (2003). Severe hypokalaemia and weakness due to Nurofen^® misuse. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 40(4). 422–423. 34 indexed citations

Neil, H. A. W., et al.. (1999). A pilot study of garlic consumption shows no significant effect on markers of oxidation or sub-fraction composition of low-density lipoprotein including lipoprotein(a) after allowance for non-compliance and the placebo effect. Clinica Chimica Acta. 285(1-2). 21–33. 33 indexed citations

Winder, A F, P. Haydn Pritchard, Donald M. Lloyd‐Jones, et al.. (1999). A first British case of fish-eye disease presenting at age 75 years: a double heterozygote for defined and new mutations affecting LCAT structure and expression.. Journal of Clinical Pathology. 52(3). 228–230. 12 indexed citations

Kari, Jameela A., Vanessa Shaw, D. Vallance, & Lesley Rees. (1998). Effect of enteral feeding on lipid subfractions in children with chronic renal failure. Pediatric Nephrology. 12(5). 401–404. 7 indexed citations

Winder, A F, W. Richmond, & D. Vallance. (1997). ACP Broad Sheet no 151: September 1997. Investigation of dyslipidaemias.. Journal of Clinical Pathology. 50(9). 721–734. 1 indexed citations

Kari, Jameela A., Ann E. Donald, D. Vallance, et al.. (1997). Physiology and biochemistry of endothelial function in children with chronic renal failure. Kidney International. 52(2). 468–472. 178 indexed citations

Mikhailidis, D.P., et al.. (1997). Tamoxifen-induced hypertriglyceridaemia. Oncology Reports. 4(3). 625–8. 16 indexed citations

Winder, A F, Richard H. Alexander, A Garner, et al.. (1996). The pathology of cornea in Tangier disease (familial high density lipoprotein deficiency).. Journal of Clinical Pathology. 49(5). 407–410. 6 indexed citations

Mikhailidis, D.P., Emmanuel S. Ganotakis, I.A. Jagroop, et al.. (1996). 55. Fibrinogen and lipoprotein(α): associations in a population attending a cardiovascular risk clinic and effect of treatment with ciprofibrate. Fibrinolysis and Proteolysis. 10. 17–17. 4 indexed citations

10.

Winder, A F, et al.. (1996). Lipid screening in an elderly population: difficulty in interpretation and in detection of occult metabolic disease.. Journal of Clinical Pathology. 49(4). 278–283. 9 indexed citations

11.

Vallance, D., et al.. (1995). Limited discriminant value of lipoprotein AI, lipoprotein Lp(a) and other lipoprotein particles in patients with and without early onset ischaemic heart disease.. Journal of Clinical Pathology. 48(1). 70–74. 4 indexed citations

12.

Mailly, F., Paul W.A. Reymer, Taco Bruin, et al.. (1995). A Common Variant in the Gene for Lipoprotein Lipase (Asp9→Asn). Arteriosclerosis Thrombosis and Vascular Biology. 15(4). 468–478. 127 indexed citations

13.

Seed, Mary, F. Mailly, D. Vallance, et al.. (1994). Lipoprotein lipase activity in patients with combined hyperlipidaemia. Journal of Molecular Medicine. 72(2). 100–106. 20 indexed citations

14.

Vallance, D., et al.. (1994). Precipitation procedures used to isolate high density lipoprotein with particular reference to effects on apo A-I-only particles and lipoprotein(a). Clinica Chimica Acta. 229(1-2). 77–85. 5 indexed citations

15.

Mailly, F., Gunilla Olivecrona, Mary Seed, et al.. (1994). A common variant in the gene for lipoprotein lipase (asp9 → asn): functional implications and prevalence in normal and hyperlipidemic subjects. Atherosclerosis. 109(1-2). 61–62. 53 indexed citations

16.

Stensel, David J., Adrianne E. Hardman, Katherine Brooke‐Wavell, et al.. (1993). Brisk Walking and Serum Lipoprotein Variables in Formerly Sedentary Men Aged 42–59 Years. Clinical Science. 85(6). 701–708. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact